Search Prime Grants

W81XWH2210389

Project Grant

Overview

Grant Description
Development of 2-deoxy-D-glucose for the treatment of polycystic kidney disease.
Awardee
Ospedale San Raffaele S.R.L
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Italy
Geographic Scope
Foreign
Related Opportunity
W81XWH21PRMRPTTDA
Ospedale San Raffaele S.R.L was awarded Development of 2-Deoxy-D-Glucose Polycystic Kidney Disease Treatment Project Grant W81XWH2210389 worth $4,343,041 from Medical Command in July 2022 with work to be completed primarily in Italy. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 6/27/22

Period of Performance
7/1/22
Start Date
6/30/26
End Date
79.0% Complete

Funding Split
$4.3M
Federal Obligation
$0.0
Non-Federal Obligation
$4.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2210389

Additional Detail

Award ID FAIN
W81XWH2210389
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
D9ECADLUG6H3
Awardee CAGE
AL154
Performance District
Not Applicable
Modified: 6/27/22